Filing metadata

Accession number
0001213900-24-072154
Form type
Form 3
Filer
Estrella Immunopharma, Inc.
CIK
CIK 1844417
Filed
Aug 23, 2024
Reporting period
Aug 14, 2024
Description
Initial ownership

Explore SEC Filings Hub